44 related articles for article (PubMed ID: 36979589)
21. A case of stercoral colitis with marked elevation of serum carcinoembryonic antigen.
Takehara K; Takehara Y; Ueyama S; Kobayashi T
Clin Case Rep; 2020 Apr; 8(4):734-738. PubMed ID: 32274048
[TBL] [Abstract][Full Text] [Related]
22. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.
Ushigome M; Shimada H; Miura Y; Yoshida K; Kaneko T; Koda T; Nagashima Y; Suzuki T; Kagami S; Funahashi K
Int J Clin Oncol; 2020 Apr; 25(4):622-632. PubMed ID: 31820210
[TBL] [Abstract][Full Text] [Related]
23. Low-cost flexible plasmonic nanobump metasurfaces for label-free sensing of serum tumor marker.
Zhu J; Wang Z; Lin S; Jiang S; Liu X; Guo S
Biosens Bioelectron; 2020 Feb; 150():111905. PubMed ID: 31791874
[TBL] [Abstract][Full Text] [Related]
24. Wash- and Amplification-Free Digital Immunoassay Based on Single-Particle Motion Analysis.
Akama K; Iwanaga N; Yamawaki K; Okuda M; Jain K; Ueno H; Soga N; Minagawa Y; Noji H
ACS Nano; 2019 Nov; 13(11):13116-13126. PubMed ID: 31675215
[TBL] [Abstract][Full Text] [Related]
25. On-a-chip Biosensing Based on All-Dielectric Nanoresonators.
Yavas O; Svedendahl M; Dobosz P; Sanz V; Quidant R
Nano Lett; 2017 Jul; 17(7):4421-4426. PubMed ID: 28616986
[TBL] [Abstract][Full Text] [Related]
26. The artificial control of enhanced optical processes in fluorescent molecules on high-emittance metasurfaces.
Iwanaga M; Choi B; Miyazaki HT; Sugimoto Y
Nanoscale; 2016 Jun; 8(21):11099-107. PubMed ID: 27227964
[TBL] [Abstract][Full Text] [Related]
27. Overcoming metal-induced fluorescence quenching on plasmo-photonic metasurfaces coated by a self-assembled monolayer.
Choi B; Iwanaga M; Miyazaki HT; Sugimoto Y; Ohtake A; Sakoda K
Chem Commun (Camb); 2015 Jul; 51(57):11470-3. PubMed ID: 26088784
[TBL] [Abstract][Full Text] [Related]
28. Paper-based electrochemical immunoassay for rapid, inexpensive cancer biomarker protein detection.
Tang CK; Vaze A; Rusling JF
Anal Methods; 2014 Nov; 6(22):8878-8881. PubMed ID: 25431626
[TBL] [Abstract][Full Text] [Related]
29. Drivers of biodiagnostic development.
Giljohann DA; Mirkin CA
Nature; 2009 Nov; 462(7272):461-4. PubMed ID: 19940916
[TBL] [Abstract][Full Text] [Related]
30. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology.
Neubig RR; Spedding M; Kenakin T; Christopoulos A;
Pharmacol Rev; 2003 Dec; 55(4):597-606. PubMed ID: 14657418
[TBL] [Abstract][Full Text] [Related]
31. Measurement of free PSA in the diagnosis and staging of prostate cancer.
Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
Int J Cancer; 1997 May; 71(5):756-9. PubMed ID: 9180142
[TBL] [Abstract][Full Text] [Related]
32. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
[TBL] [Abstract][Full Text] [Related]
33. Recent Progress in Biosensors for Detection of Tumor Biomarkers.
Li M; Jiang F; Xue L; Peng C; Shi Z; Zhang Z; Li J; Pan Y; Wang X; Feng C; Qiao D; Chen Z; Luo Q; Chen X
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364157
[TBL] [Abstract][Full Text] [Related]
34. Aptamer-based biosensor for detecting carcinoembryonic antigen.
Xiang W; Lv Q; Shi H; Xie B; Gao L
Talanta; 2020 Jul; 214():120716. PubMed ID: 32278406
[TBL] [Abstract][Full Text] [Related]
35. A novel classification of prostate specific antigen (PSA) biosensors based on transducing elements.
Najeeb MA; Ahmad Z; Shakoor RA; Mohamed AMA; Kahraman R
Talanta; 2017 Jun; 168():52-61. PubMed ID: 28391865
[TBL] [Abstract][Full Text] [Related]
36. Fluorescent Biosensors Based on Single-Molecule Counting.
Ma F; Li Y; Tang B; Zhang CY
Acc Chem Res; 2016 Sep; 49(9):1722-30. PubMed ID: 27583695
[TBL] [Abstract][Full Text] [Related]
37. Advances in prostate specific antigen biosensors-impact of nanotechnology.
Negahdary M; Sattarahmady N; Heli H
Clin Chim Acta; 2020 May; 504():43-55. PubMed ID: 32004532
[TBL] [Abstract][Full Text] [Related]
38. Biosensing strategies for diagnosis of prostate specific antigen.
Özyurt C; Uludağ İ; İnce B; Sezgintürk MK
J Pharm Biomed Anal; 2022 Feb; 209():114535. PubMed ID: 34954466
[TBL] [Abstract][Full Text] [Related]
39. Robust Detection of Cancer Markers in Human Serums Using All-Dielectric Metasurface Biosensors.
Iwanaga M
Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979589
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
